PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26586775 ↗2015Reported benefit

Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury.

RatTBIUnspecifiedSprague-DawleyMaleAcute propranolol dose followed by a delayed dose of mesenchymal stromal cells;…

Model: Moderate to severe traumatic brain injury in a rodent model; impact parameters not stated in the available text

Mesenchymal stromal cells reduced blood-brain barrier permeability at 96 h, limited thalamic microglial and macrophage activation short and long term and increased short-term neurogenesis, while propranolol reduced oedema and activated microglia. The sequential combination was well tolerated and im…

Extraction: extract · Supplied extraction confidence: 0.4. Machine-extracted fields require source verification.